FSD PHARMA INC-CLASS B (HUGE)
CA35954B4047 - Common Stock
| MRQ (2023-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.63M | 35.26M | 17.52M | 5.94M | 15.83M | |||
| Marketable Securities | 743.98K | 158.04K | N/A | N/A | N/A | |||
| Receivables | 4.52M | 500.96K | 161.34K | 1.55M | 736.02K | |||
| Inventories | N/A | N/A | 0.00 | 706.27K | N/A | |||
| Other Current Assets | 348.37K | 10.01M | 9.18M | 322.36K | 338.87K | |||
| Total Current Assets | 9.25M | 45.93M | 26.87M | 8.52M | 16.91M | |||
| Non-Current Assets | ||||||||
| PPE Net | 135.78K | 168.31K | 0.00 | 8.94M | 9.09M | |||
| Investments And Advances | 109.31K | 660.23K | 1.68M | 8.82M | 13.53M | |||
| Intangibles | 5.46M | 16.20M | 13.42M | 16.75M | N/A | |||
| Total Non-Current Assets | 9.70M | 17.03M | 15.10M | 34.51M | 22.62M | |||
| TOTAL ASSETS | 18.94M | 62.96M | 41.97M | 43.03M | 39.53M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 300.55K | 300.55K | 384.65K | 1.43M | 0.00 | |||
| Current Portion Of LT Debt. | 62.31K | 124.31K | 46.84K | 42.10K | N/A | |||
| Accrued Expenses | 1.04M | 4.46M | N/A | N/A | N/A | |||
| Accounts Payable | 2.66M | 3.00M | 3.70M | 3.35M | N/A | |||
| Other Current Liabilities | 130.38K | 825.10K | 1.45M | 1.98M | 1.31M | |||
| Total Current Liabilities | 4.20M | 8.70M | 5.58M | 6.80M | 1.31M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 131.05K | 79.12K | 109.85K | 0.00 | |||
| Total Non-Current Liabilities | -89.52K | 131.05K | 79.12K | 109.86K | 0.00 | |||
| TOTAL LIABILITIES | 4.11M | 8.83M | 5.66M | 6.91M | 1.31M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -153.82M | -121.02M | -85.90M | -54.51M | -16.53M | |||
| Additional Paid In Capital | 30.20M | 22.58M | 18.79M | 17.30M | 3.73M | |||
| Minority Interest | -89.53K | N/A | N/A | N/A | N/A | |||
| Common Shares | 137.76M | 152.32M | 103.21M | 73.42M | 51.02M | |||
| Other Shareholders' Equity | 702.46K | 239.61K | 207.80K | -84.41K | N/A | |||
| Shares Outstanding | 39.36M | 40.45M | 19.16M | 7.91M | 6.85M | |||
| Tangible Book Value per Share | 0.24 | 0.94 | 1.19 | 2.45 | 5.58 | |||
| Total Shareholders' Equity | 14.84M | 54.13M | 36.31M | 36.12M | 38.22M | |||
| TOTAL LIABILITIES AND EQUITY | 18.94M | 62.96M | 41.97M | 43.03M | 39.53M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.01 | 0.01 | 0.04 | N/A | |||
| Current Ratio | 2.20 | 5.28 | 4.82 | 1.25 | 12.94 | |||
| Return On Assets (ROA) | -119.99% | -56.04% | -75.77% | -89.30% | -43.03% | |||
| Return On Equity (ROE) | -153.19% | -65.19% | -87.58% | -106.38% | -44.50% | |||
All data in USD